- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06255925
A Strength-Based Employment Maintenance Program for Individuals on the Autism Spectrum
February 12, 2024 updated by: Kessler Foundation
The investigators are looking to evaluate how effective a training program that focuses on character strengths may be in improving job maintenance skills in young adults.
The investigators are examining the effects of this intervention in young adults who feel they would like to help in improving their satisfaction with work, and in keeping their jobs.
Study Overview
Detailed Description
Individuals with autism possess employable and valuable strengths and abilities.
Unfortunately, despite these strengths, individuals with autism experience challenges in obtaining and maintaining employment.
Traditionally, the majority of interventions designed for autism (including those focused on employment) focus on remediating deficits, without harnessing the strengths of those with autism.
This deficit-based approach (i.e. to fix what is deficient in a person with autism) has triggered increasing criticism and dissatisfaction from the autism community.
A growing shift toward strength-based training tools represent a holistic approach to treatment of autistic individuals by acknowledging and using their strengths to improve outcomes.
To date, no strength-based employment programs have been examined in individuals with autism.
Thus, in the current project, the investigators aim to develop and test a strength-based employment program.
At Kessler Foundation, the investigators have developed a strength-based training tool: Kessler Foundation Strength Identification and Expression (KF-STRIDE®) which targets job interview skills by teaching individuals with autism to identify and express their personal strengths to a future employer.
In the current proposal, the investigators aim to adapt this program to specifically target job maintenance skills.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Helen Genova, Ph. D.
- Phone Number: 973-324-8390
- Email: hgenova@kesslerfoundation.org
Study Locations
-
-
New Jersey
-
East Hanover, New Jersey, United States, 07936
- Recruiting
- Kessler Foundation
-
Contact:
- Helen Genova, Ph. D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Lives in the United States of America
- Between the ages of 14-26
- Speaks English well and at a 4th grade reading level
Exclusion Criteria:
- Had a stroke, Traumatic Brain Injury, or neurological injury or disease in the past(like brain tumor or epilepsy)
- Has a history of significant psychiatric illness(like schizophrenia or psychosis)
- Has uncontrolled seizures or other unstable medical complications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment Group
In this arm, participants would participate in in an intervention program that uses character strengths to improve job maintenance skills in young adults.
|
Treatment group will receive 10 web based sessions of a strength-based training tool(once or twice a week).
Sessions are approximately 60 minutes long.
Other Names:
|
No Intervention: Control Group
In this arm, participants are services as usual and will participate in their regular activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parent Report Employment Questionnaire
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Consists of questions answered by parents regarding employment difficulties in their children .
Questions of employment valued by yes or no, with yes being valued higher.
And amount of hours worked from 0-40, with higher score indicating a better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Work Self-Efficacy Scale
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
10 items, scores range from 10-50 with higher scores indicating perceived work capability.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Strengths Self-Efficacy Scale
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Measures the level of one's confidence in her/his ability to practice and apply her/his strengths.
34 items, scores range from 0-340
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Strengths Knowledge and Strengths Use Scale(SKUS)
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Measure to assess knowledge and use of one's strengths and measure changes following strengths-based interventions.
Two scores: Strengths Use and Strengths Knowledge.
Strengths Use values range from 14-98, with higher score indicating a better outcome.
Strengths Knowledge values range from 8-56, with higher score indicating a better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Flourishing(FS)
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Measure of well-being and "flourishing".
Values range from 8-56, with higher score indicating a better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Patients Global Impression of Change
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Measure of perception of intervention resulting in meaningful change for a participant's life.
6 Items, with higher score indicating effectiveness of positive change.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Intervention Effectiveness From Participant Point
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Measure of perception of intervention resulting in meaningful change for a participant's life.
15 Items, with higher score indicating effectiveness of positive change.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Minnesota Work Satisfaction
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
20 item part 1, scores range from 20-100.
Measure of present job satisfaction, with higher scores indicating higher job satisfaction.
8 item part 2 with open-ended questions, there is no maximum or minimum.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Job search
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
12 item, 0-60 with the higher score indicating the greater level of job search behaviors.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Search for Work Self-Efficacy Scale
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
12 items, scores range from 12-60.
Items concern one's perception of their capability to select among job offers, to build strategies for the attainment of a goal, to respect other people's competences, and to work with new members, to manage time difficulties, and stressful situations typical of job searches, to consider a failure a challenge rather than a problem.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Connor- Davidson Resilience Scale(CD-RISC)
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
10 items, scores range from 0 to 40.
Lower scores indicate less resilience and higher scores indicate greater resilience.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Voicemail Elicitation Task(VET)/ Email Elicitation Task(EET)
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Measures how individuals respond to social situations using politeness/impoliteness.
Values are calculated by dividing the total number of politeness markers by the total time in minutes, with a higher score indicating a better outcome.
There are no minimum or maximum values for this test.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Work Chat Assessment
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Measure of work place appropriate behavior.
Participants interact with a virtual human avatar in various scenarios.
Higher scores indicate more appropriate work place behavior.
Minimum of 0 and Maximum of 100.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Rosenberg Self-Esteem Scale(RSES)
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Self-report self-esteem questionnaire.
Values range from 10-40, with higher score indicating better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Twenty Statements Task
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
20-item questionnaire used to measure an individual's self concept filling out the twenty items that each start with the words "I am..." which will be analyzed for positive and negative valence, with higher score indicating a better outcome.
There is no maximum or minimum value for this test.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Helen Genova, Ph. D., Kessler Foundation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
June 1, 2025
Study Registration Dates
First Submitted
January 16, 2024
First Submitted That Met QC Criteria
February 12, 2024
First Posted (Actual)
February 13, 2024
Study Record Updates
Last Update Posted (Actual)
February 13, 2024
Last Update Submitted That Met QC Criteria
February 12, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-1199-22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism
-
EarliTec Diagnostics, IncMarcus Autism CenterRecruitingAutism Spectrum Disorder | Developmental Delay | Autism | Autism, Early Infantile | Autism, InfantileUnited States
-
IRIS Media IncCompletedAutism DisorderUnited States
-
University of California, San FranciscoWithdrawn
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
Forest LaboratoriesMerz Pharmaceuticals GmbHCompletedAutism | Pediatric AutismUnited States
-
University of Medicine and Dentistry of New JerseyNational Alliance for Autism ResearchCompleted
-
The Hong Kong Polytechnic UniversityRecruitingAutism Spectrum Disorder | High-functioning AutismHong Kong
-
Emory UniversityNational Institute of Mental Health (NIMH)Terminated
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); Florida State University; Autism...CompletedAutism Spectrum DisordersUnited States
-
University Hospital, MontpellierCaisse Nationale de Solidarité pour l'AutonomieActive, not recruitingAutism Spectrum DisordersFrance
Clinical Trials on KF-STRIDE® Into Work!
-
Kessler FoundationCompleted
-
Kessler FoundationNot yet recruitingA Strength-Based Intervention to Improve Job Interview Skills in Young Adults in a Community SettingAutism Spectrum Disorder
-
Kessler FoundationCompletedAutism Spectrum Disorder | Autism | ASDUnited States
-
Kessler FoundationNational Multiple Sclerosis SocietyRecruitingMultiple SclerosisUnited States
-
Arthrex, Inc.Recruiting
-
University of BrasiliaCompletedMuscle Weakness | Body Composition, Beneficial | Mental RetardationBrazil
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Advanced Biliary Tract Cancer | Female Reproductive System Neoplasm | MSI-H Solid Malignant TumorNew Zealand, Australia
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Canada, Italy, Japan, Portugal, Spain, United Kingdom
-
ExelixisArcus Biosciences, Inc.RecruitingAdvanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid TumorsUnited States